Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Linezolid PK/PD in MDR-TB
NCT02778828Completed
- Sponsor
- Fondation Hôpital Saint-Joseph
- Start
- Nov 2015
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of linezolid in Tuberculosis (TB), sponsored by Fondation Hôpital Saint-Joseph. Primary endpoints: Area Under the Curve at 1 day, Minimum Inhibitory Concentration at 1 day and 1 more. Started Nov 2015; status: completed.
02
Drugs
linezolid
03
Conditions
Tuberculosis (TB)
Beyond the preview
Go deeper on NCT02778828.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02778828.